OptiBiotix Health Plc Total Assets

Latest as of June 2025: GBX9.15 Million GBX ≈ $1.11K USD

OptiBiotix Health Plc total assets. Based on the latest financial reports, OptiBiotix Health Plc (OPTI) holds total assets worth GBX9.15 Million GBX (≈ $1.11K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see OPTI company net worth for the company's overall valuation and market capitalisation.

Total Assets of OptiBiotix Health Plc (2008–2024)

Total assets of OptiBiotix Health Plc from 2008 to 2024. This chart illustrates how OptiBiotix Health Plc's total assets have evolved over time, based on quarterly financial data. See current stock price of OptiBiotix Health Plc for real-time trading data and today's change.

OptiBiotix Health Plc - Asset Composition Analysis

OptiBiotix Health Plc Total Assets Breakdown (December 2024)

OptiBiotix Health Plc total assets breakdown as of December 2024. OptiBiotix Health Plc's total assets of GBX9.15 Million consist of 15.7% current assets and 84.3% non-current assets.

Asset Category Amount (GBX) % of Total Assets
Cash & Equivalents GBX0.00 8.2%
Accounts Receivable GBX433.00K 4.8%
Inventory GBX230.00K 2.5%
Property, Plant & Equipment GBX0.00 0.0%
Intangible Assets GBX1.12 Million 12.4%
Goodwill GBX0.00 0.0%

Asset Composition Trend (2008–2024)

This chart illustrates how OptiBiotix Health Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore OptiBiotix Health Plc (OPTI) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: OptiBiotix Health Plc's current assets represent 15.7% of total assets in 2024, a decrease from 100.0% in 2008.
  • Cash Position: Cash and equivalents constituted 8.2% of total assets in 2024, down from 99.4% in 2008.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 0.0% in 2008.
  • Asset Diversification: The largest asset category is intangible assets at 12.4% of total assets.

OptiBiotix Health Plc Competitors by Total Assets

Key competitors of OptiBiotix Health Plc based on total assets are shown below.

Company Country Total Assets
Samsung Biologics Co Ltd
KO:207940
Korea ₩12.65 Trillion
Verona Pharma plc
F:I9SA
Germany €572.87 Million
Asymchem Laboratories Tian Jin Co Ltd
SHE:002821
China CN¥20.70 Billion
Immunovant Inc
NASDAQ:IMVT
USA $852.49 Million
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578
China CN¥8.59 Billion
Tubize-Fin
BR:TUB
Belgium €1.99 Billion
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
China CN¥37.46 Billion
Amicus Therapeutics Inc
NASDAQ:FOLD
USA $949.87 Million

OptiBiotix Health Plc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 4.61 6.18 5.25
Quick Ratio 3.75 5.36 4.98
Cash Ratio 0.00 0.00 0.00
Working Capital GBX1.66 Million GBX1.62 Million GBX1.78 Million

OptiBiotix Health Plc - Advanced Valuation Insights

This section examines the relationship between OptiBiotix Health Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.71
Latest Market Cap to Assets Ratio 0.01
Asset Growth Rate (YoY) -3.8%
Total Assets GBX9.04 Million
Market Capitalization $70.38K USD

Valuation Analysis

Below Book Valuation: The market values OptiBiotix Health Plc's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: OptiBiotix Health Plc's assets decreased by 3.8% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for OptiBiotix Health Plc (2008–2024)

The table below shows the annual total assets of OptiBiotix Health Plc from 2008 to 2024.

Year Total Assets Change
2024-12-31 GBX9.04 Million
≈ $1.10K
-3.82%
2023-12-31 GBX9.40 Million
≈ $1.14K
-18.57%
2022-12-31 GBX11.55 Million
≈ $1.41K
-42.67%
2021-12-31 GBX20.14 Million
≈ $2.45K
+47.01%
2020-12-31 GBX13.70 Million
≈ $1.67K
+101.75%
2019-12-31 GBX6.79 Million
≈ $826.40
-15.41%
2018-11-30 GBX8.03 Million
≈ $976.96
+4.70%
2017-11-30 GBX7.67 Million
≈ $933.12
+35.41%
2016-11-30 GBX5.66 Million
≈ $689.10
+29.55%
2015-11-30 GBX4.37 Million
≈ $531.93
-15.58%
2014-11-30 GBX5.18 Million
≈ $630.08
+1618.08%
2013-11-30 GBX301.42K
≈ $36.67
-64.11%
2012-07-31 GBX839.82K
≈ $102.18
+7.12%
2010-07-31 GBX784.00K
≈ $95.39
-4.62%
2009-07-31 GBX822.00K
≈ $100.01
-6.16%
2008-07-31 GBX876.00K
≈ $106.58
--

About OptiBiotix Health Plc

LSE:OPTI UK Biotechnology
Market Cap
$70.38K
GBX578.48 Million GBX
Market Cap Rank
#31614 Global
#1157 in UK
Share Price
GBX5.60
Change (1 day)
+0.00%
52-Week Range
GBX4.85 - GBX8.35
All Time High
GBX128.00
About

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential… Read more